文献速递系统性红斑狼疮

系统性红斑狼疮患者肾脏受累可以预测吗:一项带独立验证的回顾性队列研究

Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该回顾性队列研究在「Attikon」狼疮队列570例系统性红斑狼疮患者中分析后续肾脏受累的预测因素,中位随访期间21.9%出现狼疮性肾炎;男性、诊断年龄低于26岁、高抗dsDNA滴度及低补体C3和/或C4为预测因素,四者组合风险极高(aHR 88.77),并在克里特大学狼疮登记处独立验证结果一致。

要点

  • 男性、诊断年龄低于26岁、高抗dsDNA滴度及低C3和/或C4与后续肾脏受累相关。
  • 四因素组合者较血清学不活跃、年长女性风险约高88.77倍(aHR 88.77;95%CI 18.75, 420.41)。
  • 独立验证队列结果与原始队列一致,支持上述预测因素。

核心结论

  • 男性、较年轻年龄及诊断时血清学活动与系统性红斑狼疮后续肾脏受累强烈相关。
  • 作者认为对这些患者亚组应保持警惕性监测并考虑早期使用改善病情药物。

研究设计与样本

  • 回顾性队列研究,来自「Attikon」狼疮队列的570例系统性红斑狼疮患者为推导队列。
  • 狼疮性肾炎定义为肾脏组织学和/或分类标准,基线人口学与临床特征与未发生狼疮性肾炎者比较。
  • 采用多变量Cox比例风险模型识别独立预测因素,并在克里特大学狼疮登记处进行独立验证。

主要发现

  • 570例推导队列中59例以狼疮性肾炎为首发表现,另66例随访期间发生狼疮性肾炎,合计发生率21.9%。
  • 后续肾脏受累的基线预测因素:男性aHR 4.31(95%CI 1.82, 10.2);诊断年龄低于26岁aHR 3.71(95%CI 1.84, 7.48);高抗dsDNA滴度aHR 2.48(95%CI 1.03, 5.97);低C3和/或C4 aHR 2.24(95%CI 0.83, 6.05;P=0.11),未达统计学显著。
  • 诊断时上述因素组合者较血清学不活跃、年长女性风险约高88.77倍(aHR 88.77;95%CI 18.75, 420.41),提示极高危组。
  • 克里特狼疮登记处独立验证结果与原始队列一致。

临床怎么用

  • 作者认为对男性、诊断年龄较轻及诊断时血清学活动的患者亚组应保持警惕性监测并考虑早期使用改善病情药物。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To discern predictive factors for incident kidney involvement in patients with SLE. METHODS: Patients with SLE from the 'Attikon' Lupus cohort were monitored for LN, defined by kidney histology and/or classification criteria. Demographic and clinical characteristics at baseline were compared against patients who did not develop LN. LN-free Kaplan-Meier survival curves were generated. A multivariate Cox proportional hazards model was used to identify independent predictors of LN. Independent validation was performed in the University of Crete Lupus registry. RESULTS: Among the 570 patients in the derivation cohort, 59 exhibited LN as their initial presentation, while an additional 66 developed LN during the follow-up period (collectively, 21.9% incidence). In the latter group, baseline factors predictive of subsequent kidney involvement were male sex [multivariable-adjusted hazard ratio (aHR) 4.31; 95% CI: 1.82, 10.2], age of SLE diagnosis below 26 years (aHR 3.71; 95% CI: 1.84, 7.48), high anti-dsDNA titre (aHR 2.48; 95% CI: 1.03, 5.97) and low C3 and/or C4 (although not statistically significant, aHR 2.24; 95% CI: 0.83, 6.05; P = 0.11). A combination of these factors at time of diagnosis conferred an almost 90-fold risk compared with serologically inactive, older, female patients (aHR 88.77; 95% CI: 18.75, 420.41), signifying a very high-risk group. Independent validation in the Crete Lupus registry showed concordant results with the original cohort. CONCLUSION: Male sex, younger age and serological activity at SLE diagnosis are strongly associated with subsequent kidney involvement. Vigilant surveillance and consideration of early use of disease-modifying drugs is warranted in these subsets of patients.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Katechis S, Nikolopoulos D, Flouda S, et al. Can we predict kidney involvement in patients with systemic lupus erythematosus? A retrospective cohort study with independent validation. Rheumatology (Oxford). 2025. PMID: 38745434. doi:10.1093/rheumatology/keae278

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。